Review: surgical treatment of giant coronary aneurysms in pediatric patients with Kawasaki disease
Sign Up to like & getrecommendations! Published in 2017 at "General Thoracic and Cardiovascular Surgery"
DOI: 10.1007/s11748-017-0877-7
Abstract: In Kawasaki disease (KD), giant coronary aneurysms in the proximal segments of the coronary arteries have long been among the serious complications associated with acute myocardial infarction. To treat myocardial ischemia in children, Kitamura et… read more here.
Keywords: patients kawasaki; giant coronary; treatment; kawasaki disease ... See more keywords
Differential protein analysis of serum exosomes post-intravenous immunoglobulin therapy in patients with Kawasaki disease
Sign Up to like & getrecommendations! Published in 2017 at "Cardiology in the Young"
DOI: 10.1017/s1047951117001433
Abstract: Abstract Background Kawasaki disease, which is characterised by systemic vasculitides accompanied by acute fever, is regularly treated by intravenous immunoglobulin to avoid lesion formation in the coronary artery; however, the mechanism of intravenous immunoglobulin therapy… read more here.
Keywords: intravenous immunoglobulin; immunoglobulin therapy; patients kawasaki; kawasaki disease ... See more keywords
Association of steroid administration with larger coronary artery abnormalities in patients with Kawasaki disease.
Sign Up to like & getrecommendations! Published in 2022 at "Cardiology in the young"
DOI: 10.1017/s1047951122002104
Abstract: We sought to elucidate the risk profiles of patients with Kawasaki disease who developed coronary artery abnormalities through a retrospective analysis with special reference to steroid treatment. Demographics of the patients were obtained from medical… read more here.
Keywords: artery; steroid group; patients kawasaki; coronary artery ... See more keywords
Increased Interleukin-35 suppresses peripheral CD14+ monocytes function in patients with Kawasaki disease
Sign Up to like & getrecommendations! Published in 2020 at "BMC Immunology"
DOI: 10.1186/s12865-020-00348-x
Abstract: Interleukin-35 (IL-35) is a newly identified IL-12 cytokine family member, which regulates the activity of immune cells in infectious diseases and autoimmune disorders. However, the regulatory function of IL-35 in Kawasaki disease is not well… read more here.
Keywords: kawasaki disease; cd14; patients kawasaki; cell ... See more keywords